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KOMPOSIT KALSIUM FOSFAT- NANO TIUB KARBON BERBILANG 
SEBAGAI PENGGANTI TULANG MELALill PENYUNTIKAN 
ABSTRAK 
Semen kalsium fosfat (CPCs) telah menunjukkan prestasi yang sangat baik sebagai 
bahan pengganti tulang tanpa kesan sampingan dalam kedua-dua in vitro dan in vivo. 
Namun, kelemahan CPCs mengakibatkan ia mengalami kekuatan mampatan yang 
rendah dan membataskan kebolehgunaannya dalam ortopedik. Oleh sebab itu, tujuan 
projek ini adalah untuk menghasilkan bahan pengganti tulang yang boleh suntik dan 
CPCs yang mengandungi pelbagaijenis nano tiub karbon berbilang (MWCNTs) dan, 
"bovine serum albumin" (BSA) bagi membentukkan CPCIMWCNTs/BSA komposit 
dengan tujuan memperbaiki kekuatan mampatan bagi CPCs tulen. Kehadiran 
MWCNTs dan BSA mempunyai kesan yang signifikan dalam mempengaruhi 
morfologi hidroksiapatit (HA) kristal dalam matriks CPCs. BSA bertindak sebagai 
mangkin pertumbuhan HA pada permukaan CPCs. Dengan demikian, penambahan 
MWCNTs dan BSA menyebabkan peningkatan kekuatan mampatan dengan 
mengubahsuaikan ciri-ciri kristalit untuk komposit. Bagi proses pembelajaran yang 
sistematik, rekabentuk eksperimen (DOE) digabungkan dengan metodologi · 
permukaan sambutan (RSM) dan rekabentuk ujikaji gabungan pusat (CCD) telah 
digunakan untuk mengkaji hubungkait antara kekuatan mampatan bagi komposit 
dengan parameter yang dikaji. Matlumat ini seterusnya digunakan untuk tujuan 
pengoptimuman kekuatan mampatan. Ujian kekuatan mampatan, pengimbasan 
mikroskop elektron (SEM), spektroskopi inframerah transformasi Fourier (FTIR) dan 
ujian kebolehsuntikan dijalankan untuk menilai sifat-sifat bagi komposit. Keputusan 
kajian menunjukkan bahawa CPCs komposit yang mengandungi MWCNT -OH dan 
BSA menunjukkan kekuatan mampatan yang tertinggi (60 MPa) selepas 28 hari 
perendama:n dalam simulasi bendalir tubuh (SBF). 
CALCIUM PHOSPHATE-MUL TIW ALLED CARBON NANOTUBES 
COMPOSITES FOR INJECT ABLE BONE SUBSTITUTE 
ABSTRACT 
Calcium phosphate cements (CPCs) has shown very good performance as bone 
substitute material without any side effects for both in vitro and in vivo. However, 
these CPCs suffer from a relatively low compressive strength, limiting its 
applicability in orthopedics. Therefore, the aim of this project is to develop the 
injectable bone substitute (IBS) consisting of CPCs with different types of 
multiwalled carbon nanotubes (MWCNTs) and bovine serum albumin (BSA) to. 
create CPCIMWCNTs/BSA composites with the purpose of improving the 
mechanical properties of the pure CPCs. The presence of MWCNTs and BSA were 
found to have significant effects in influencing the morphology of hydroxyapatite 
(HA) crystals in CPCs matrix. BSA was found to act as promoter for HA growth 
when bounded to the surface of CPCs grains. Thus, the addition of MWCNTs and 
BSA could lead to an improvement of compressive strength by modifying the 
properties of the crystallites. In order to have a systematic process study, design of 
experiment (DOE) coupled with response surface methodology (RSM) and central 
composite design (CCD) was used to investigate the relationship between the 
compressive strength of the composites with the process parameters studied, which 
was then used for the optimization process. Compressive strength tests, scanning 
electron microscopy (SEM), Fourier transform infrared spectroscopy (FTIR) and 
injectability tests were used to evaluate the composites properties. Characterization 
results showed that CPCs composites containing hydroxyl group functionalized 
MWCNT (MWCNT-OH) and BSA exhibited the highest compressive strength (60 
MPa) after 28 days immersion in simulated body fluid (SBF). 
CHAPTER ONE: 
INTRODUCTION 
This chapter provides detail introduction of this research project. Brief 
definition, current medical problems and benefits of using injectable bone substitute 
(IBS) are included in this chapter. It concludes with the problem statement, scope of 
study, objectives and thesis organization of this research project. 
1.1 Why Injectable Bone Substitute (IBS)? 
Calcium phosphate (CaP) ceramics are the main raw materials used in blocks 
or granules for bone substitutes (Suchanek and Y oshira, 1998). These forms are 
limited value when cavities are not easily accessible or when it would be preferable 
to perform micro-invasive percutaneous surgery. Contradict to the general practice in 
visceral surgery, percutaneous surgery is less frequently than open surgery in 
orthopedics. In the present time, improvements in specific instrumentation and the 
use of bioresorbable polymer implants for bone fracture healing have contributed to 
the development of this minimal invasive technique. Thus, there is a need to develop 
IBS (Weiss et a/., 1999; Daculsi et a/., 1999). illS requires suitable properties to 
ensure bonding of the mineral phase in situ with good cell permeability. Contradict 
to the use of dense materials which do not have any inherent porosity, this approach 
provides rapid improvement in deep bone formation. ms could be produced in a 
sterile stage ready to use. Its stable composition and mechanical properties are 
suitable for the reproducibility of the biological response. A list of desirable 
properties for an ideal IBS, as identified by different workers (Heini and Berleman, 
2001; Phillips, 2003) is presented in Table 1.1. The most important properties are 
easy injectability, high radiopacity, dough viscosity that does not change much 
between mixing and delivery into the vertebral body, a resorption rate that is neither 
too fast nor too slow and mechanical properties that are comparable to those of a 
healthy intact vertebral body (Heini and Berleman, 2001 ). 
Table 1.1: Desirable properties of an ideal IBS (Heini and Berlemann, 2001; Phillips, 
2003). 
• Very high radiopacity 
• Ease of preparation and handling 
• Very easy injectability into the 
collapsed vertebral body 
• No toxicity 
• Low cost 
• Low curing temperature 
• Working time of about 6-10 min 
• Setting time of about 15 min 
• Resorption rate that is neither too 
high nor too low 
• Excellent osteoconductivity 
• Excellent osteoinductivity 
• Excellent biocompatibility 
• Excellent bioactivity 
• Adequate mechanical properties that would allow for immediate reinforcement of 
the vertebral body and ensure early ambulation of the patient; for example, values 
of modulus of elasticity and strength should be comparable to those of a healthy 
vertebral body 
• Appropriate cohesion; that is, dough sets in a fluid without disintegration (this is 
achieved by keeping a high viscosity for the dough) 
• A curing dough whose initial viscosity is low (but not low enough to have the 
potential for extravasation) and a change in that viscosity that is practically 
invariant with setting time 
• Microporosity (mean pore diameter< 10 JJ.m), to allow circulation of body fluid 
• Macroporosity (mean pore diameter> 100 Jlm), to provide a scaffold for blood-
cell colonization 
Furthermore, there has been considerable work on the development of IBS 
materials to improve the currently surgical implant method (Grimandi et al., 1998; 
Knaack et al., 1998; Gauthier et al., 1999; Tamada et al., 1999). IBS formulations 
are attractive since they can be used for the purpose of minimally invasive surgical 
procedures and can be molded to exactly fill irregular bone defects (Peter et al., 
1998). Grimandi et al. (1998) and Gauthier et al. (1999) worked on an IBS composed 
of a methylhydroxypropylcellulose (MHPC) matrix incorporating bicalcium 
phosphate (BCP) granules. Both groups found that the IBS provides an excellent 
bioactive matrix for bone ingrowth promoting cell colonization, but the material is 
lacked suitable mechanical properties. The latter group also distinguished that 
smaller BCP granules obtained greater inflammatory response, with macrophages 
being recruited to the implant site. This in turn tended to increase the degradation 
rate of the bone substitute, apparently through signaling and recruitment of other 
bone remodeling cells (Daculsi eta/., 1995; Grimandi eta/., 1998; Gauthier eta/., 
1999). To improve the mechanical properties of an IBS and to stabilize it at the 
implant site, many researchers investigated alternatives to IBS formulations that set 
in situ, primarily through cross linking reactions. Polyalkenoate cements, used as . 
dental cements and fillers, consist of a basic metal oxide like zinc oxide and a 
polyacid, such as poly( acrylic acid) (P AA). The acid reacts with the base to form a 
cross linked metal-polyacrylate salt. In order to improve the bioactivity of these 
cements, Kenny et a/. (2000) mixed apatite into the formulations and varied the 
molecular weight of the polyacid. They obtained cements that set at body 
temperature, with the potential to chemically bond to bone, exhibit no shrinkage and 
possess mechanical properties comparable to acrylic cements. The mechanical 
performance of these systems improved with increasing polyacid molecular weight. 
Watson eta/. (1999) reacted tetracalcium phosphate (TTCP) with PAA, forming a 
cross linked hydroxyapatite (HA)-calcium polyacrylate composite. In aqueous 
solution, TTCP hydrolyzes to HA and the calcium cation neutralize the P AA, 
forming the cross linked network. The reaction between TTCP and P AA was very 
fast and controlled by prehydration of the TTCP to form a slower reacting HA 
surface layer. In contrast, Reed et a/. (1996) synthesized a dicarboxy 
polyphosphazene that can be cross linked by di- or trivalent cation. The cations are 
calcium ions from ITCP and dicalcium phosphate dehydrate (DCPD). They obtained 
cements with a compressive strength of the order of 10 MPa and 65 % porosity. 
Mimicking the setting of polymethylmethacrylate (PMMA) cements, Peter et a/. 
(1999) used a vinyl monomer to crosslink poly(propylene-co-fumarate) (PPF). They 
were able to make quick setting, degradable cements, with low heat output and 
compressive strengths in the range of 1-12 MPa by varying the PPF molecular 
weight, as well as monomer, initiator and porogens content like sodium chloride 
(NaCl). Li et a/. (2000) prepared an acrylic cement with a strontium-containing HA 
(Sr-HA) that cured at temperatures lower than PMMA-based cements, but with 
comparable mechanical properties, with the intention that the Sr-HA would improve. 
the ability to bond the bone. Finally, a novel IBS was described by Turczyn eta/. 
(2000), where a silanized hydroxyethylcellulose carrier was mixed with BCP. The 
suspension was in liquid form at pH 10-12, but gels quickly at pH< 9. 
Self-setting calcium phosphate cements (CPCs) have been first expanded and 
many of them are commercially available (Frankenburg et a/., 1998; Larsson and 
Bauer, 2002; Cassidy et a/., 2003). IDS are being developed based on the suspension 
of CaP granules in a carrier phase consisting of polymeric water solution of non-
ionic cellulose ether especially for the application in invasive surgery and drug 
delivery system. The resulting composite provides a ready to use, sterile, injectable 
material (Daculsi eta/., 1995; Grimandi et a/., 1998). Such IBS have shown ability to 
support more extensive and early bone substitution than macroporous implants or 
CaP bone cement but have not been yet studied for biomechanical competence after 
implantation (Gauthier eta/., 1999; Gauthier eta/., 2003). 
Two different types of IBS compounds have been developed for example 
CPCs that harden in situ and exhibit interesting mechanical properties and IBS 
associating with polymer and CaP mineral phase, which possess osteoconduction 
qualities similar to those of macroporous ceramics (Iijima, 1991; Munting et a/., 
1993; Miyamoto eta/., 1997; Bo eta/., 1999; Grimandi eta/., 1998; Gauthier, Boix 
eta/., 1999). New injectable biomaterials consisting ofbioactive CaP ceramics fillers 
and hydrophilic polymer matrix were studied by Weiss et a/. (1999) for bone and 
dental surgery. 
In summary, IBS represent an ideal material for many bone reprur. 
applications provided that the osteoconductive properties and ease of use can be 
associated with adequate mechanical properties. It is also clear that any effort to 
develop IBS should include a fundamental examination of all items listed in Table 
1.2 (Kenny and Buggy, 2003). Furthermore, IBS materials should exhibit good 
workability, have a suitable set time with low heat output, good mechanical 
properties, non-toxic, biocompatible, osteoconductive and they should integrate with 
bone over the time scale of bone ingrowth and remodeling (Rafal, 2001). 
Table 1.2: List of criteria for the design of new IBS materials (Kenny and Buggy, 
2003). 
Criterion 
Mechanical properties to match 
those ofbone 
Quick setting ( 5-15 minutes) 
In situ setting at body 
temperature 
Bonding to bone and medical 
grade alloys 
Bioactive bone in-growth 
Radio opaque 
Purpose 
Enhance the elimination of the phenomenon 
known as stress shielding 
To assists in clinical use and after care of patient 
Elimination of necrosis of the adjacent tissue 
Elimination of fibrous capsule and thus loosening 
of the implant 
Enhancing both stress transfer and chemical 
attachment of the implant 
Subsequent monitoring of implant 
The advantages of injectable CPC include easy placement in surgery, able to 
be used in difficult surgical sites that are not freely accessible by open surgery, 
capable of filling narrow defects and facilitating minimally invasive techniques. 
Furthermore, to improve the mechanical properties of CPCs, many researchers have 
blended polymers, organic or inorganic additives, bioglass and carbon nanotubes 
(CNTs) with the cements (Low eta/., 2010). 
1.2 Problem Statement 
Due to increasing of population agemg, osteoporosis is becoming 
progressively a more common medical problem leading to higher rate of bone. 
fractures (Bohner eta/., 2003). For example vertebral fractures, may cause persistent, 
often excruciating pain, which impairs mobility and reduces the patient's quality of 
life. Management of vertebral bone fractures includes analgesics, bed rest and 
external bracing. Even with these types of treatment, progressive kyphosis, 
prolonged pain and disability still may occur. A major clinical problem with a high 
risk of severe kyphosis can develop such as multiple contiguous compression 
fractures in the thoracic and thoracolumbar spine. Therefore, there is a need for 
treatment that could decrease the occurrence of these fractures and improve 
management options once these fractures occur. It has been demonstrated that using 
minimally invasive bone cement injection for stabilizing osteoporosis or treating 
vertebral bone fracture has significant clinical benefits. At present, there is an 
increase in the usage of cement augmentation techniques such as vertebroplasty and 
kyphoplasty for treating persistent painful vertebral compression fractures (Bo et a/., 
1999). One extensive category of potential intervention involves the fortification or 
augmentation of the vertebral bones. In addition to prophylactically stabilizing 
osteoporotic bones at risk for fracture, augmentation of vertebral bones that already 
have fractured may prove useful by reducing pain, improving function and 
preventing further collapse and deformation (Bostrom et a/., 1997). 
Therefore, there are several limitations and problems faced for IBS. Hence, 
this research is carried out focusing on the development of CPC composites and it 
application as IBS. The study will also focus on how to improve the CPC mechanical 
properties by using multiwalled CNTs (MWCNTs) and overcome their drawback 
which limits its clinical use such as, low mechanical strength and poor injectability. 
Besides, the bovine serum albumin (BSA) was also incorporated in the CPC. 
composites in order to improve the mechanical properties by promoting the HA 
crystal growth. 
l.3 Scope of Study 
CPCs are bone substitute material which has shown very good performance 
without outside effects, both in vitro and in vivo (Knaack et a/., 1998; Lee et al., 
1999). However, the final cement suffers from a relatively low compressive strength, 
limiting its applicability in orthopedics. The aim of this project is to develop IBS 
consisting of CPC with different types and weight percent (wt %) of MWCNTs and 
different wt % of BSA to create CPC/MWCNTs/BSA composites with the purpose 
of improving the mechanical properties of the CPC. Drawing on the results from the 
literature, MWCNTs have been chosen as a result of their impressive list of 
superlatives including mechanical strength, stiffuess and their applications m 
biological and biomedical systems. BSA acts as promoters of CaP crystal growth 
when bound to a surface and hence has also included in this study. Thus, the addition 
of MWCNTs and BSA could lead to an improvement of mechanical properties by 
modifying the properties of the crystallites, thereby possibly resulting in a composite 
of higher density and improved mechanical properties. The composites formulated 
will be expected to exhibit compressive strengths higher than the pure IBS material. 
In each case, characterization techniques will be considered to evaluate the final 
product properties. Moreover, the interfacial bonding between the phases, CPC, 
MWCNTs and BSA which is an important consideration for composite materials will 
also considered. Finally, the biocompatibility of selected samples will be carried out 
by in-vitro for biological evaluation. 
The compressive strength of the CPC/MWCNTs/BSA composites will also 
be studied and performed using design of experiment (DOE) occupying response 
surface methodology (RSM) coupled with central composite design (CCD) with the 
assistant of Design Expert 6.0.6 software. 
1.4 Objectives 
The aim of this project is: 
1. To develop IBS consisting ofCPC with different types ofMWCNTs (e.g. as-
pristine MWCNT (MWCNT -AP), hydroxyl group functionalized MWCNT 
(MWCNT -OH) and carboxyl group functionalized MWCNT (MWCNT-
COOH)), different wt % of respective MWCNTs and BSA to create 
CPCIMWCNTs/BSA composites with the purpose of improving the 
compressive strength and injectability of the CPC. 
n. To optimize the compressive strength of the CPC/MWCNTs/BSA composites 
produced using RSM couple with CCD. 
111. To study the in vitro biological test on the optimum CPCIMWCNTs/BSA 
composites. 
1.5 Organization of The Thesis 
This thesis consists of five chapters. Chapter one provides an outline of the 
overall research project including introduction on IBS. Problem statement was 
written after reviewing the current scenario of the CPC. The problem statement 
reveals the problems faced by the surgical implant and the importance of this 
research project. The original objectives of this research project were then carefully 
formulated with the intention to address the problems encountered by the bone . 
fracture patients. Lastly, the organization of the thesis highlights the content of each 
chapter. 
Chapter two gives an overall review of various research works reported in the 
literature in this area of study which includes properties of CPC, MWCNTs and BSA, 
also the current status of using MWCNTs in the CPC and its application are reported 
in the review. 
~xperimental materials and methodology were discussed in chapter three. 
This chapter describes details information on the overall flow of this research works 
and some experimental methods in conducting this research project. In addition, 
material, chemicals and equipments used in this study were also reported. This 
chapter also includes the information required for the calculation of injectability and 
compressive strength. The characterization process and data analysis also will be 
including in this chapter. 
Chapter four perhaps is the heart of the thesis since it includes detail 
discussion on the results obtained in the present research work. This chapter consists 
of four sections which have been divided according to the stages of this research 
work. First section described the formation of CPCIMWCNTs/BSA composites in 
details. Section two of this chapter presents the investigated the effect of different 
types of MWCNTs, different wt % of MWCNTs and BSA in the compressive 
strength of the CPC composites by using the DOE approach before further 
experimental works were carried out. At the end of this section, characterization of 
CPC/MWCNTs/BSA composites produced under optimum conditions was reported. 
This section also reports the characterization result of CPCIMWCNTs/BSA. 
composites for the effect of using different types of MWCNTs. Process study on the 
compressive strength ofCPC/MWCNTs/BSA composites was being discussed in this 
section. Section three will discuss on the in vitro biological evaluation result for the 
CPCIMWCNTs/BSA composites. 
Chapter five, the last chapter of this thesis, provides a summary on the results 
obtained in this research project. This chapter concludes the overall research project 
and gives some recommendations for future studies related to this research works; 
